Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine crossover study of alpha2-adrenergic receptors in bone remodeling
NL-OMON23544Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of clonidine in osteoporosis (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Change in serum CTX. Started Jan 2013; status: active, not recruiting.
02
Drugs
clonidine
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NL-OMON23544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23544.